- Home
- HUMA vs UROY Comparison
HUMA vs UROY Comparison
Compare HUMA & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- UROY
- Stock Information
- Founded
- HUMA 2004
- UROY 2017
- Country
- HUMA United States
- UROY Canada
- Employees
- HUMA N/A
- UROY N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- UROY
- Sector
- HUMA Health Care
- UROY
- Exchange
- HUMA Nasdaq
- UROY Nasdaq
- Market Cap
- HUMA 250.2M
- UROY 336.8M
- IPO Year
- HUMA N/A
- UROY N/A
- Fundamental
- Price
- HUMA $1.51
- UROY $3.15
- Analyst Decision
- HUMA Strong Buy
- UROY Strong Buy
- Analyst Count
- HUMA 8
- UROY 2
- Target Price
- HUMA $10.88
- UROY $4.00
- AVG Volume (30 Days)
- HUMA 5.9M
- UROY 2.6M
- Earning Date
- HUMA 08-11-2025
- UROY 07-16-2025
- Dividend Yield
- HUMA N/A
- UROY N/A
- EPS Growth
- HUMA N/A
- UROY N/A
- EPS
- HUMA N/A
- UROY N/A
- Revenue
- HUMA $818,000.00
- UROY $11,285,840.00
- Revenue This Year
- HUMA N/A
- UROY $228.36
- Revenue Next Year
- HUMA $949.92
- UROY N/A
- P/E Ratio
- HUMA N/A
- UROY N/A
- Revenue Growth
- HUMA N/A
- UROY N/A
- 52 Week Low
- HUMA $1.15
- UROY $1.43
- 52 Week High
- HUMA $6.77
- UROY $3.30
- Technical
- Relative Strength Index (RSI)
- HUMA 36.87
- UROY 65.88
- Support Level
- HUMA $1.43
- UROY $2.51
- Resistance Level
- HUMA $1.67
- UROY $2.87
- Average True Range (ATR)
- HUMA 0.15
- UROY 0.16
- MACD
- HUMA -0.01
- UROY 0.05
- Stochastic Oscillator
- HUMA 23.32
- UROY 82.05
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.